LONDON, September 7 /PRNewswire/ -- Clinical research professionals from all over the world gathered at the Gibson Hall in London last night for the inaugural Good Clinical Practice Journal (GCPj) Awards. Opening this landmark event, Chairman of the Commission on Human Medicines Professor Sir Gordon Duff said the awards were a most important celebration of innovation and enterprise in the development of new medicines. "I hope it will become a traditional event in the public health calendar", he told the 200+ audience.
The host for the evening, Dr Phil Hammond, a GP, writer, broadcaster and comedian, mixed laughter - "the best form of medicine according to the ho ho ho holistic humour institute!" with more serious issues. He bemoaned the poor headlines in the press relating to the pharmaceutical industry, clinical trials and the NHS and stressed the need for an awards programme like the GCPj Awards to highlight the achievements of clinical research.
GCPj editor Jenine Willis said "These awards are GCPj's chance to show industry's commitment to improving healthcare through innovative, high quality, rigorous clinical research. Better healthcare not only benefits society as a whole, it has a direct impact on the global economy and raising quality of life everywhere. Of course this is a serious business, but GCPj launched these awards to celebrate these achievements and tell the wider world about them too."
Individuals, teams and organisations were recognised by the 11 awards categories. The first company to receive an accolade was Pfizer who won the Most Successful Global Trial, which was sponsored by the global clinical research organisation (CRO) Kendle. The trial in question recruited renal cancer patients at 101 sites in 11 countries.
Accepting the award, Deborah Roberts from Pfizer UK Oncology said "It's
an honour and a privilege to accept this award on behalf of all of the
Pfizer team who have worked to develop Sutent and have throug
'/>"/>
| SOURCE GCPj Awards Copyright©2007 PR Newswire. All rights reserved |